¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"inflammatory tissue reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • labile oxidase reaction
    ºÒ¾ÈÁ¤»êÈ­È¿¼Ò¹ÝÀÀ
  • lengthening reaction
    1. ´ÃÀÓ¹ÝÀÀ, ½ÅÀå¹ÝÀÀ 2. ±Ù´ÃÀÓ¹ÝÀÀ
  • lepra reaction
    ³ªº´¹ÝÀÀ
  • lepromin reaction
    ·¹ÇÁ·Î¹Î¹ÝÀÀ
  • leukemoid reaction
    ¹éÇ÷º´¸ð¾ç¹ÝÀÀ
  • leukoerythroblastic reaction
    ¹éÀûÇ÷¸ð±¸¹ÝÀÀ
  • labyrinthine righting reaction
    ¹Ì·Î¹Ù·ÎÀâ±â¹ÝÀÀ
  • ligation reaction
    °áÂû¹ÝÀÀ
  • luminous reaction
    ¹ß±¤¹ÝÀÀ
  • lymphocytic leukemoid reaction
    ¸²ÇÁ±¸¹éÇ÷º´¸ð¾ç¹ÝÀÀ
  • lytic reaction
    ¿ë±Õ¹ÝÀÀ, ¿ëÇØ¹ÝÀÀ
  • minor reaction
    ºÎÂ÷¹ÝÀÀ
  • Mitsuda reaction
    ¹ÌÃß´Ù¹ÝÀÀ
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed order reaction
    È¥ÇÕ¼ø¼­¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • flocculation reaction
    ¼ØÅÐħÀü¹ÝÀÀ
  • foot placement reaction
    ¹ß³õ±â¹ÝÀÀ
  • footpad reaction
    ¹ß¹Ù´Ú¹ÝÀÀ
  • fuchsin number reaction
    Ç«½Å¼ö¹ÝÀÀ
  • fuchsinophil reaction
    Ç«½Åģȭ¹ÝÀÀ
  • reaction fever
    ¹ÝÀÀ¿­
  • reaction formation
    ¹Ýµ¿Çü¼º, ¹ÝÀÀÇü¼º
  • gel diffusion precipitin reaction
    ¿ì¹«È®»êħÀü¹ÝÀÀ
  • gluteal reaction
    º¼±â¹ÝÀÀ
  • graft versus host reaction
    ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
  • grief reaction
    ¾Öµµ¹ÝÀÀ, ºñ¾Ö¹ÝÀÀ
  • gross stress reaction
    ´ëÀڱعÝÀÀ, ÃÑüÀû½ºÆ®·¹½º¹ÝÀÀ
  • hemagglutination-inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ
  • hemoclastic reaction
    Ç÷±¸ºØ±«¹ÝÀÀ
  • hemolytic transfusion reaction
    ¿ëÇ÷¼öÇ÷¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • reaction substance
    ¹ÝÀÀ¹°Áú(ÚãëëÚªòõ).
  • reaction threshold
    ¹ÝÀÀ¿ªÄ¡(ÚãëëÚÊö·).
  • reaction time
    ¹ÝÀÀ½Ã(°£)(ÚãëëãÁÊà).
  • recurrent reaction
    Àç¹ß¹ÝÀÀ(î¢Û¡Úãëë).
  • red reaction
    ¹ßÀûÀÛ¿ë.
  • redox reaction
    »êȭȯ¿ø¹ÝÀÀ(ß«ûùü»êª Úãëë).
  • rejection reaction
    °ÅÀý(¹ÝÀÀ)(ËÞï¾Úãëë).
  • rejection reaction
    °ÅÀý(¹ÝÀÀ)(ËÞï¾Úãëë).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • soft tissue calcification
    ¿¬Á¶Á÷¼®È¸È­(¡­à´üéûù)
  • soft tissue technique
    ¿¬Á¶Á÷ ±â¹ý
  • space, retropharyngeal soft tissue
    ÀεÎÈĺο¬ºÎÁ¶Á÷
  • special connective tissue
    Ư¼ö°áÇÕÁ¶Á÷(÷å â¨Ì¿ùêðÚòÄ).
  • stationary tissue
    Á¤ Á¶Á÷
  • subconjunctival tissue
    °á¸·ÇÏÁ¶Á÷(¡­ðÚòÄ).
  • subconjunctival tissue
    °á¸·¹ØÁ¶Á÷
  • subcutaneous fatty tissue
    ÇÇÇÏÁö¹æÁ¶Á÷.
  • subcutaneous tissue
    ÇǺιØÁ¶Á÷, ÇÇÇÏÁ¶Á÷ (ù«ù»ðÚòÄ).
  • subcutaneous tissue
    ÇǺιØÁ¶Á÷
  • subcutaneous tissue
    ÇÇÇÏÁ¶Á÷
  • subcutis => subcutaneous tissue
  • submucosal tissue
    Á¡¸·¹ØÁ¶Á÷
  • submucous tissue
    Á¡¸·¹ØÁ¶Á÷, Á¡¸·ÇÏÁ¶Á÷(ïÄØ¯ù»ðÚòÄ).
  • submucous tissue
    Á¡¸·¹ØÁ¶Á÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
MCTD Mixed Connective Tissue Disease
NTV Nervous Tissue Vaccine; ½Å°æ Á¶Á÷ ¹é½Å
rt-PA recombinant tissue-Plasminogen Activator
  = Alteplase
tPA tissue Plasminogen Activator
AT abdominal thrusts; achievement test; Achilles tendon; Achard-Thiers [syndrome]; adaptive thermogenes...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
rt-PA Recombinant human tissue plasminogen activator
rt-PA Recombinant human tissue-type plasminogen activator
rTFPI Recombinant tissue factor pathway inhibitor
r-TPA Recombinant tissue plasminogen activator
SLC Secondary Lymphoid-tissue Chemokine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • magnet reaction
    ÀÚ¼® ¹ÝÀÀ
  • monomolecular reaction
    ´Ü ºÐÀÚ ¹ÝÀÀ
  • Nadi reaction
    ³ªµð ¹ÝÀÀ
    ³ªµð ½Ã¾àÀ» µ¿¹°¿¡ ÁÖ»çÇϸé, Ä¡ÅäÅ©·Ò »êÈ­ È¿¼ÒÀÇ ÀÛ¿ë¿¡ ÀÇÇØ Ä¡ÅäÅ©·ÒÀ¸·ÎºÎÅÍ Àεµ Æä³î ûÀÌ Çü¼ºµÇ´Â ¹ÝÀÀÀÌ´Ù.
  • Napier's reaction
    ³ªÇÇ¾î ¹ÝÀÀ
    Ä®¶ó¾ÆÀÚ¸£¸¦ Áø´ÜÇÏ´Â µ¥ »ç¿ëµÇ´Â ¹ÝÀÀÀ¸·Î, Ç÷û 1 cc¿¡ Æ÷¸£¸»¸° ÇÑ ¹æ¿ïÀ» °¡ÇѸé, ±Û·ÎºÒ¸°ÀÇ Áõ°¡·Î ÀÎÇØ ¹éŹÀÌ ¹ß»ýÇÏ´Â Çö»óÀÌ´Ù.
  • Neill-Mooser reaction
    ´Ò-¹«Àú ¹ßÁø¿­ °Ë»ç
  • ninhydrin reaction
    ´ÑÈ÷µå¸° ¹ÝÀÀ
    µ¿ÀǾî=Abderhalden's reaction. ¸ðµç ´Ü¹éÁú ¹× ¾Æ¹Ì³ë»ê¿¡ ƯÀÌÇÑ ¹ÝÀÀÀ¸·Î, ²úÀ̸é û»öÀÌ µÇ°í, ÇǸ®µò¿¡ ÀÇÇØ ´õ¿í ÁøÇØÁö´Â ÀӽйÝÀÀ.
  • nitroso- ´ÏÆ®·Î¼Ò ¶Ç´Â ´ÏÆ®·Î½ÇÀ» ÇÔÀ¯Çϰí ÀÖÀ½À» ³ªÅ¸³»´Â Á¢µÎ¾î.

    nitrosoindol reaction

    ´ÏÆ®·Î Àε¹ ¹ÝÀÀ
  • nociceptive reaction
    Ä§ÇØ ¹ÝÀÀ
  • nonspecific reaction
    ºñƯÀÌ ¹ÝÀÀ
  • order of reaction
    ¹ÝÀÀ Â÷¼ö
  • overanxious reaction
    °úºÒ¾È ¹ÝÀÀ
  • oxidase reaction
    »êÈ­ È¿¼Ò ¹ÝÀÀ
  • pain reaction
    µ¿Åë ¹ÝÀÀ
  • panic reaction
    °øÈ² ¹ÝÀÀ
    ±ØµµÀÇ ¶Ç´Â ºÒÇÕ¸®ÇÑ °øÆ÷¿Í ºÒ¾È µîÀÇ ¹ÝÀÀÀ» º¸ÀÌ´Â °Í.
  • periosteal reaction
    °ñ¸· ¹ÝÀÀ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
allergic reaction <immunology> The bodys response to an allergic stimulus. This can be localised to one area or generalised and may include: rash, itching, hives, swelling, difficulty breathing, and/or low blood pressure.
(27 Sep 1997)
amphoteric reaction A double reaction possessed by certain fluids which have a combination of acid and alkaline properties.
(05 Mar 2000)
anamnestic reaction Augmented production of an antibody due to previous response of the subject to stimulus by the same antigen.
(05 Mar 2000)
anaphylactic reaction <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing.
(27 Sep 1997)
anaplerotic reaction <biochemistry> An enzyme-catalysed chemical reaction that recharges the supply of intermediate molecules in various metabolic reactions such asthe citric acid cycle.
(09 Oct 1997)
antigen-antibody reaction The phenomenon, occurring in vitro or in vivo, of antibody combining with antigen of the type that stimulated the formation of the antibody, thereby resulting in agglutination, precipitation, complement fixation, greater susceptibility to ingestion and destruction by phagocytes, or neutralization of exotoxin.
See: skin test.
(05 Mar 2000)
anxiety reaction A sudden bout of anxiety that is often accompanied by the features of hyperventilation (tingling around mouth and in fingertips, rapid breathing, faintness or fainting).
(27 Sep 1997)
Arias-Stella reaction Focal, unusual, decidual changes in endometrial epithelium, consisting of intraluminal budding, and nuclear enlargement and hyperchromatism with cytoplasmic swelling and vacuolation; may be associated with ectopic or uterine pregnancy.
Synonym: Arias-Stella effect, Arias-Stella reaction.
(05 Mar 2000)
arousal reaction Change in pattern of the brain waves when the subject is suddenly awakened and becomes alert.
(05 Mar 2000)
Arthus reaction <dermatology, immunology> A localised inflammation due to injection of antigen into an animal that has a high level of circulating antibody against that antigen.
A haemorrhagic reaction with oedema occurs due to the destruction of small blood vessels by thrombi. It may occur, as in Farmer's Lung, as a reaction to natural exposure to antigen.
(18 Nov 1997)
arthus-type reaction's Reaction's in man and other species that result from the same basic immunologic (allergic) mechanism which evokes, in the rabbit, the typical Arthus phenomenon.
See: immune complex disease.
(05 Mar 2000)
Ascoli reaction A method for confirming the diagnosis of anthrax by means of a precipitin reaction which indicates the presence of heat-stable Bacillus anthracis antigen in the extracted tissue.
(05 Mar 2000)
associative reaction A secondary or side reaction.
(05 Mar 2000)
basic reaction Any test by which an alkaline reaction is recognised, such as the change of red litmus paper to blue, an excess of hydroxide ions over hydrogen ions in aqueous solution as indicated by a pH value greater than 7 (at 22°C).
Compare: dissociation constant of water.
Synonym: basic reaction.
(05 Mar 2000)
beam-beam reaction <radiobiology> Fusion reaction which occurs from the collision of two fast ions originating in injected neutral beams.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á